Search Results - "O'CONNOR, J. B"

Refine Results
  1. 1

    Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD by Singh, D, Brooks, J, Hagan, G, Cahn, A, O'Connor, B J

    Published in Thorax (01-07-2008)
    “…The combination of salmeterol and fluticasone propionate (SFC) and tiotropium bromide (TIO) are commonly used treatments in chronic obstructive pulmonary…”
    Get more information
    Journal Article
  2. 2

    DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents by O'CONNOR, J. P. B, JACKSON, A, PARKER, G. J. M, JAYSON, G. C

    Published in British journal of cancer (29-01-2007)
    “…Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is now frequently used in early clinical trial assessment of antiangiogenic and vascular…”
    Get full text
    Journal Article
  3. 3

    Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics by Diamant, Z., Sidharta, P. N., Singh, D., O'Connor, B. J., Zuiker, R., Leaker, B. R., Silkey, M., Dingemanse, J.

    Published in Clinical and experimental allergy (01-08-2014)
    “…Summary Background CRTH2 is a G‐protein‐coupled receptor on T helper2 cells that mediates pro‐inflammatory effects of prostaglandin D2 in allergic responses…”
    Get full text
    Journal Article
  4. 4

    The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma by Leaker, B. R., Barnes, P. J., O'Connor, B. J., Ali, F. Y., Tam, P., Neville, J., Mackenzie, L. F., MacRury, T.

    Published in Clinical and experimental allergy (01-09-2014)
    “…Summary Background SH2‐containing inositol‐5′‐phosphatase 1 (SHIP1) is an endogenous inhibitor of the phosphoinositide‐3‐kinase pathway that is involved in the…”
    Get full text
    Journal Article
  5. 5

    Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway by Leaker, B R, Nicholson, G C, Ali, F Y, Daudi, N, O'Connor, B J, Barnes, P J

    Published in Respiratory research (04-09-2015)
    “…Current techniques used to obtain lung samples have significant limitations and do not provide reproducible biomarkers of inflammation. We have developed a…”
    Get full text
    Journal Article
  6. 6

    The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma by Kent, S. E., Boyce, M., Diamant, Z., Singh, D., O'Connor, B. J., Saggu, P. S., Norris, V.

    Published in Clinical and experimental allergy (01-02-2013)
    “…Summary Background GSK2190915, a potent 5‐lipoxygenase‐activating protein inhibitor, prevents the synthesis of leukotrienes and…”
    Get full text
    Journal Article
  7. 7

    The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: Report on the cleveland clinic barrett’s esophagus registry by O’Connor, J.Barry, Falk, Gary W, Richter, Joel E

    Published in The American journal of gastroenterology (01-08-1999)
    “…OBJECTIVE: The reported incidence of adenocarcinoma in Barrett’s esophagus is variable. The aim of this study was to determine the incidence of dysplasia and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects by Brown, R. A, Clarke, G. W, Ledbetter, C. L, Hurle, M. J, Denyer, J. C, Simcock, D. E, Coote, J. E, Savage, T. J, Murdoch, R. D, Page, C. P, Spina, D, O'Connor, B. J

    Published in The European respiratory journal (01-02-2008)
    “…Asthmatics, unlike healthy subjects, experience bronchoconstriction in response to inhaled adenosine, and extracellular adenosine concentrations are elevated…”
    Get full text
    Journal Article
  10. 10

    A reformulation of pLSA for uncertainty estimation and hypothesis testing in bio-imaging by Tar, P D, Thacker, N A, Deepaisarn, S, O’Connor, J P B, McMahon, A W

    Published in Bioinformatics (01-07-2020)
    “…Abstract Motivation Probabilistic latent semantic analysis (pLSA) is commonly applied to describe mass spectra (MS) images. However, the method does not…”
    Get full text
    Journal Article
  11. 11

    Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract by Kharitonov, S A, Chung, K F, Evans, D, O'Connor, B J, Barnes, P J

    “…Nitric oxide (NO) is detectable in the exhaled air of human subjects, and its concentration is increased in patients with asthma. We have investigated the…”
    Get more information
    Journal Article
  12. 12

    DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 by O'Connor, J P B, Rose, C J, Jackson, A, Watson, Y, Cheung, S, Maders, F, Whitcher, B J, Roberts, C, Buonaccorsi, G A, Thompson, G, Clamp, A R, Jayson, G C, Parker, G J M

    Published in British journal of cancer (28-06-2011)
    “…Background: There is limited evidence that imaging biomarkers can predict subsequent response to therapy. Such prognostic and/or predictive biomarkers would…”
    Get full text
    Journal Article
  13. 13

    Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid by Keatings, V M, Evans, D J, O'Connor, B J, Barnes, P J

    Published in Thorax (01-04-1997)
    “…BACKGROUND: Analysis of bronchoalveolar lavage fluid has improved our understanding of the pathogenesis of asthma. Safety issues and access to expert resources…”
    Get full text
    Journal Article
  14. 14

    novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity by Lethbridge, M.W, Kemeny, D.M, Ratoff, J.C, O'Connor, B.J, Hawrylowicz, C.M, Corrigan, C.J

    Published in Clinical and experimental immunology (01-09-2010)
    “…Bronchial mucosal CD8⁺ cells are implicated in chronic obstructive pulmonary disease (COPD) pathogenesis, but there are few data on their functional…”
    Get full text
    Journal Article
  15. 15

    A new method for the high-precision assessment of tumor changes in response to treatment by Tar, P D, Thacker, N A, Babur, M, Watson, Y, Cheung, S, Little, R A, Gieling, R G, Williams, K J, O'Connor, J P B

    Published in Bioinformatics (01-08-2018)
    “…Abstract Motivation Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave…”
    Get full text
    Journal Article
  16. 16

    Heparin and structurally related polymers attenuate eotaxin‐1 (CCL11) release from human airway smooth muscle by Kanabar, V, Page, C P, Simcock, D E, Karner, C, Mahn, K, O'Connor, B J, Hirst, S J

    Published in British journal of pharmacology (01-06-2008)
    “…Background and purpose: The glycosaminoglycan heparin has anti‐inflammatory activity and is exclusively found in mast cells, which are localized within airway…”
    Get full text
    Journal Article
  17. 17

    A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma by Evans, David J, Taylor, David A, Zetterstrom, Olle, Chung, K. Fan, O'Connor, Brian J, Barnes, Peter J

    Published in The New England journal of medicine (13-11-1997)
    “…Inhaled glucocorticoids have become the mainstay of therapy in asthma, with dose titration until control is achieved. 1 Although it is effective, the long-term…”
    Get full text
    Journal Article
  18. 18

    Inhaled endotoxin in healthy human subjects: A dose-related study on systemic effects and peripheral CD4+ and CD8+ T cells by Loh, L.C., Vyas, B., Kanabar, V., Kemeny, D.M., O’Connor, B.J.

    Published in Respiratory medicine (01-03-2006)
    “…Inhaled endotoxin or lipopolysaccharide (LPS) is implicated in the pathogenesis of pulmonary diseases. We investigated the inhalation effects of two different…”
    Get full text
    Journal Article
  19. 19

    Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose by Davies, R.J., Stampone, P., O'Connor, B.J.

    Published in Respiratory medicine (01-06-1998)
    “…The mandatory requirement to eliminate chlorofluorocarbons (CFCs) as propellants in pharmaceutical aerosols has provided the opportunity to enhance…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Effect of inhaled budesonide on lung function and airway inflammation : Assessment by various inflammatory markers in mild asthma by LIM, S, JATAKANON, A, JOHN, M, GILBEY, T, O'CONNOR, B. J, KIAN FAN CHUNG, BARNES, P. J

    “…In a double-blind, cross-over study, we examined the effect of inhaled budesonide (800 microgram twice daily via Turbohaler) on lung function and various…”
    Get full text
    Journal Article